JP2012024601A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012024601A5 JP2012024601A5 JP2011209922A JP2011209922A JP2012024601A5 JP 2012024601 A5 JP2012024601 A5 JP 2012024601A5 JP 2011209922 A JP2011209922 A JP 2011209922A JP 2011209922 A JP2011209922 A JP 2011209922A JP 2012024601 A5 JP2012024601 A5 JP 2012024601A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- transducer
- interest
- region
- probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000011282 treatment Methods 0.000 claims description 216
- 239000000523 sample Substances 0.000 claims description 138
- 238000002604 ultrasonography Methods 0.000 claims description 87
- 210000001519 tissue Anatomy 0.000 claims description 83
- 238000000034 method Methods 0.000 claims description 78
- 210000003491 skin Anatomy 0.000 claims description 61
- 210000004207 dermis Anatomy 0.000 claims description 57
- 230000006378 damage Effects 0.000 claims description 34
- 208000035484 Cellulite Diseases 0.000 claims description 31
- 206010049752 Peau d'orange Diseases 0.000 claims description 31
- 230000036232 cellulite Effects 0.000 claims description 31
- 230000008569 process Effects 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 18
- 238000012546 transfer Methods 0.000 claims description 18
- 239000010410 layer Substances 0.000 claims description 17
- 230000003796 beauty Effects 0.000 claims description 16
- 210000003205 muscle Anatomy 0.000 claims description 11
- 230000009471 action Effects 0.000 claims description 9
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 9
- 239000002344 surface layer Substances 0.000 claims description 9
- 238000007920 subcutaneous administration Methods 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 6
- 230000004130 lipolysis Effects 0.000 claims description 6
- 230000001926 lymphatic effect Effects 0.000 claims description 6
- 210000001789 adipocyte Anatomy 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 4
- 238000006241 metabolic reaction Methods 0.000 claims description 4
- 230000035699 permeability Effects 0.000 claims description 4
- 238000001243 protein synthesis Methods 0.000 claims description 4
- 230000014616 translation Effects 0.000 claims description 4
- 230000001766 physiological effect Effects 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 230000037323 metabolic rate Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 description 42
- 238000002560 therapeutic procedure Methods 0.000 description 39
- 230000001225 therapeutic effect Effects 0.000 description 33
- 230000008878 coupling Effects 0.000 description 29
- 238000010168 coupling process Methods 0.000 description 29
- 238000005859 coupling reaction Methods 0.000 description 29
- 210000003041 ligament Anatomy 0.000 description 29
- 238000003384 imaging method Methods 0.000 description 28
- 230000005540 biological transmission Effects 0.000 description 27
- 210000004204 blood vessel Anatomy 0.000 description 26
- 230000002123 temporal effect Effects 0.000 description 25
- 210000003195 fascia Anatomy 0.000 description 22
- 210000001577 neostriatum Anatomy 0.000 description 22
- 210000000481 breast Anatomy 0.000 description 21
- 239000003925 fat Substances 0.000 description 21
- 238000002679 ablation Methods 0.000 description 19
- 208000019553 vascular disease Diseases 0.000 description 16
- 210000003462 vein Anatomy 0.000 description 16
- 210000002615 epidermis Anatomy 0.000 description 15
- 230000003902 lesion Effects 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 238000009210 therapy by ultrasound Methods 0.000 description 13
- 238000001816 cooling Methods 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 12
- 238000003491 array Methods 0.000 description 11
- 230000001815 facial effect Effects 0.000 description 11
- 238000009826 distribution Methods 0.000 description 10
- 208000009056 telangiectasis Diseases 0.000 description 10
- 230000004927 fusion Effects 0.000 description 9
- 230000033001 locomotion Effects 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 206010059245 Angiopathy Diseases 0.000 description 7
- 210000002808 connective tissue Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 206010046996 Varicose vein Diseases 0.000 description 6
- 206010053648 Vascular occlusion Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 206010040925 Skin striae Diseases 0.000 description 5
- 230000003044 adaptive effect Effects 0.000 description 5
- 210000002414 leg Anatomy 0.000 description 5
- 230000004807 localization Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000825 pharmaceutical preparation Substances 0.000 description 5
- 208000027185 varicose disease Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 239000011149 active material Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000007665 sagging Methods 0.000 description 4
- 208000032544 Cicatrix Diseases 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003176 fibrotic effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 230000037387 scars Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 201000002282 venous insufficiency Diseases 0.000 description 3
- 239000002918 waste heat Substances 0.000 description 3
- 208000009443 Vascular Malformations Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 210000000617 arm Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000004146 energy storage Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 201000011066 hemangioma Diseases 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 229910052451 lead zirconate titanate Inorganic materials 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 238000002600 positron emission tomography Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000000250 revascularization Effects 0.000 description 2
- 238000007632 sclerotherapy Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 230000003685 thermal hair damage Effects 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 230000007838 tissue remodeling Effects 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010067193 Naevus flammeus Diseases 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 229920001363 Polidocanol Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000029152 Small face Diseases 0.000 description 1
- 206010062696 Spider vein Diseases 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- 206010057165 Venous varices Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- DUPIXUINLCPYLU-UHFFFAOYSA-N barium lead Chemical compound [Ba].[Pb] DUPIXUINLCPYLU-UHFFFAOYSA-N 0.000 description 1
- 229910002113 barium titanate Inorganic materials 0.000 description 1
- JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- NKZSPGSOXYXWQA-UHFFFAOYSA-N dioxido(oxo)titanium;lead(2+) Chemical compound [Pb+2].[O-][Ti]([O-])=O NKZSPGSOXYXWQA-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 208000002026 familial multiple nevi flammei Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229940036998 hypertonic sodium chloride Drugs 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- HFGPZNIAWCZYJU-UHFFFAOYSA-N lead zirconate titanate Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Zr+4].[Pb+2] HFGPZNIAWCZYJU-UHFFFAOYSA-N 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- GQYHUHYESMUTHG-UHFFFAOYSA-N lithium niobate Chemical compound [Li+].[O-][Nb](=O)=O GQYHUHYESMUTHG-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000007500 overflow downdraw method Methods 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 1
- 229960002226 polidocanol Drugs 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 238000001314 profilometry Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 239000003229 sclerosing agent Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 208000020854 vein disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61635504P | 2004-10-06 | 2004-10-06 | |
| US61675304P | 2004-10-06 | 2004-10-06 | |
| US60/616,753 | 2004-10-06 | ||
| US60/616,355 | 2004-10-06 | ||
| US61629404P | 2004-10-07 | 2004-10-07 | |
| US61733804P | 2004-10-07 | 2004-10-07 | |
| US60/617,338 | 2004-10-07 | ||
| US60/616,294 | 2004-10-07 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007535860A Division JP2008522642A (ja) | 2004-10-06 | 2005-10-06 | 美容強化のための方法およびシステム |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014091514A Division JP2014158953A (ja) | 2004-10-06 | 2014-04-25 | 美容強化のための方法およびシステム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012024601A JP2012024601A (ja) | 2012-02-09 |
| JP2012024601A5 true JP2012024601A5 (enrdf_load_stackoverflow) | 2013-10-31 |
| JP5769566B2 JP5769566B2 (ja) | 2015-08-26 |
Family
ID=45778228
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011209922A Expired - Fee Related JP5769566B2 (ja) | 2004-10-06 | 2011-09-26 | 美容強化のための方法およびシステム |
| JP2014091514A Withdrawn JP2014158953A (ja) | 2004-10-06 | 2014-04-25 | 美容強化のための方法およびシステム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014091514A Withdrawn JP2014158953A (ja) | 2004-10-06 | 2014-04-25 | 美容強化のための方法およびシステム |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JP5769566B2 (enrdf_load_stackoverflow) |
| IL (4) | IL241684B (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9566454B2 (en) | 2006-09-18 | 2017-02-14 | Guided Therapy Systems, Llc | Method and sysem for non-ablative acne treatment and prevention |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413550A (en) * | 1993-07-21 | 1995-05-09 | Pti, Inc. | Ultrasound therapy system with automatic dose control |
| US5660836A (en) * | 1995-05-05 | 1997-08-26 | Knowlton; Edward W. | Method and apparatus for controlled contraction of collagen tissue |
| JP4322322B2 (ja) * | 1997-03-31 | 2009-08-26 | 株式会社東芝 | 超音波治療装置 |
| US6050943A (en) * | 1997-10-14 | 2000-04-18 | Guided Therapy Systems, Inc. | Imaging, therapy, and temperature monitoring ultrasonic system |
| US6595934B1 (en) * | 2000-01-19 | 2003-07-22 | Medtronic Xomed, Inc. | Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
| SE0100160D0 (sv) * | 2001-01-22 | 2001-01-22 | Atos Medical Ab | Method and apparatus for high energetic ultrasonic tissue treatment |
| EP1466648B1 (en) * | 2001-12-17 | 2011-04-06 | Chongqing Haifu(Hifu)Technology Co., Ltd | Ultrasonic treatment device |
| EP1470546B1 (en) * | 2002-01-29 | 2013-11-27 | SRA Developments Limited | Method and apparatus for focussing ultrasonic energy |
| KR100923717B1 (ko) * | 2002-06-25 | 2009-10-27 | 울트라세이프 인코포레이티드 | 신체 미용에 유용한 디바이스 및 방법 |
| EP3138524B1 (en) * | 2004-04-01 | 2023-01-04 | The General Hospital Corporation | Apparatus for dermatological treatment and tissue reshaping |
-
2011
- 2011-09-26 JP JP2011209922A patent/JP5769566B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-25 JP JP2014091514A patent/JP2014158953A/ja not_active Withdrawn
-
2015
- 2015-09-17 IL IL241684A patent/IL241684B/en active IP Right Grant
-
2018
- 2018-03-07 IL IL257938A patent/IL257938B/en unknown
-
2021
- 2021-03-18 IL IL281624A patent/IL281624B2/en unknown
-
2023
- 2023-03-12 IL IL301311A patent/IL301311B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008522642A (ja) | 美容強化のための方法およびシステム | |
| US11179580B2 (en) | Energy based fat reduction | |
| JP6284663B2 (ja) | 超音波組織処理ための方法およびシステム | |
| US20060079868A1 (en) | Method and system for treatment of blood vessel disorders | |
| US20240115885A1 (en) | Energy based fat reduction | |
| JP5769566B2 (ja) | 美容強化のための方法およびシステム | |
| JP2012024601A5 (enrdf_load_stackoverflow) |